FarmaGill SRL
FarmaGill reported total assets of 8,566 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of FarmaGill shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -41 % Total assets -3 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
FarmaGill's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
FarmaGill's financial analysis
- Solvency43.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of FarmaGill
FarmaGill's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0773.921.428
- VAT number
- BE0773921428
- Peppol
- Registered · 0208:0773921428 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Sep 2021
- Registered office
- 5600 Philippeville
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
FarmaGill (SRL) has been based in Philippeville since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,388 € and equity of 3,714 €; its revenue is not published. Its solvency stands at 43.4%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to FarmaGill
Companies in the same business, of comparable size and area, outside its group.
- Au Pave D' Ollignies Retail sale of pharmaceutical products Mouscron · balance sheet 7,469 €
- Pharma Switch Retail sale of pharmaceutical products Merchtem · balance sheet 9,444 €
- Croixssance Pharma Retail sale of pharmaceutical products Zaventem · balance sheet 9,474 €
- Farmaco Retail sale of pharmaceutical products Ranst · balance sheet 17,325 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Polderstad Retail sale of pharmaceutical products Stabroek · balance sheet 3,969 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
Frequently asked questions about FarmaGill
What is the revenue of FarmaGill?
FarmaGill files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of FarmaGill?
In Belgium, the VAT number is the company number prefixed with BE: BE0773921428 for FarmaGill, if the company is VAT-registered. Its company number (CBE) is 0773.921.428.
Where is the registered office of FarmaGill?
According to the CBE register, the registered office of FarmaGill is in 5600 Philippeville.
What is the equity of FarmaGill?
At the close of the 2025 financial year, the equity of FarmaGill amounts to 3,714 €, a solvency of 43.4% of total assets.
Who manages FarmaGill?
The register lists 1 active mandates at FarmaGill. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of FarmaGill
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →